Sangamo Biosciences, Inc. (SGMO) Posts Q3 EPS Loss of $0.18, Sales Fall Short
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -19.8%
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -19.8%
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $2.82 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sangamo Therapeutics explores strategic alternatives with Raymond James
- Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue
- Oxford Industries (OXM) Tops Q1 EPS by 12c; Offers Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
